🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
This study has been designed to evaluate whether "anti-angiogenesis" therap...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
1998-08
Trial ID
NCT00083551
This phase III trial compares the effect of olaparib for one year versus tw...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-03-12
Trial ID
NCT06580314
Treatments Being Tested
This phase II/III compares the standard therapy (chemotherapy plus cetuxima...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2023-03-13
Trial ID
NCT05063552
This phase II trial compares the usual treatment alone (carboplatin, pemetr...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-03-22
Trial ID
NCT05001880
The purpose of this study is to compare two different approaches to treatin...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-11
Trial ID
NCT01017874
Treatments Being Tested
This is an open-label, randomised, two-arm, phase III, multi-centre clinica...
Status
Active Not Recruiting
Location
Hospital General Universitario de Alicante
Start Date
2021-01-13
Trial ID
NCT04564157
Treatments Being Tested
This is an open-label, non-randomised, phase II, multicenter clinical trial...
Status
Active Not Recruiting
Location
ICO Badalona, Hospital Germans Trias i Pujol
Start Date
2021-11-18
Trial ID
NCT05012254
Treatments Being Tested
CCCG-ALL2025 LR-B-ALL plan is designed based on the CCCG-ALL2020 plan. This...
Status
Recruiting
Location
Anhui Medical University Second Affiliated Hospital
Start Date
2025-03-03
Trial ID
NCT06882057
Treatments Being Tested